SAN CARLOS, Calif., Nov. 23, 2016 /PRNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (ALCF) has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity. Every dollar donated to the Lung Cancer Foundation on #GivingTuesday will ensure that patients get state of the art immunotherapy or chemotherapy that is personalized to their genetics and type of cancer. One out of 15 people will be diagnosed with lung cancer, but it doesn't have to be a death sentence thanks to lung cancer advocates at the ALCF.
Taking place this year on November 29, #GivingTuesday is held annually on the Tuesday after Thanksgiving to kick-off the holiday giving season and inspire people to give to the causes that are close to their heart.
Why give to the ALCF on #GivingTuesday? Lung cancer is the number one cancer killer worldwide and because diagnosis for the majority of patients comes so late that they die within one year. Donating to the ALCF will allow patients to receive early detection screenings, receive genetic testing, pay for drug treatment research and ultimately find a cure. Integral is dispelling the stigma of lung cancer as a smoker's disease, misinformation that has led to lung cancer lagging behind other forms of cancer in terms of research dollars.
"Because we are patient founded, focused and funded, we know how to answer their questions and support their immediate and long-term needs. To this end, we fund clinical research and provide patient programs, give patients hope and ensure that their voices are heard in advocating for changes to transform Lung Cancer into a manageable, chronic disease and ultimately, a curable disease," said Bonnie J. Addario, a Stage 3 lung cancer survivor and the founder of ALCF.
The Addario Lung Cancer Medical Institute (ALCMI), created in 2008, connects scientists, researchers and physicians worldwide, leading and empowering patients to campaign toward better treatment options through improved coordination among leading cancer centers.
Those who are interested in joining The Bonnie J. Addario Lung Cancer Foundation #GivingTuesday initiative can visit https://www.supportalcf.org/GivingTuesday2016. For more details about the #GivingTuesday movement, visit the #GivingTuesday website (www.givingtuesday.org), Facebook page or follow @GivingTues and the #GivingTuesday hashtag on social media.
About the Bonnie J. Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation's goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors, and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised over $30 million for lung cancer research and related programs.
#GivingTuesday is a movement to celebrate and provide incentives to give—the 2016 iteration will be held on November 29, 2016. This effort harnesses the collective power of a unique blend of partners—nonprofits, businesses and corporations as well as families and individuals—to transform how people think about, talk about and participate in the giving season. #GivingTuesday inspires people to take collaborative action to improve their local communities, give back in better, smarter ways to the charities and causes they celebrate and help create a better world. #GivingTuesday harnesses the power of social media to create a global moment dedicated to giving around the world.
Last updated on: 25/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.